Adult zebrafish model of bacterial meningitis in Streptococcus agalactiae infection

Developmental and Comparative Immunology

Volumn 38, Issue 3, 2012, Pages 447-455

  Patterson, Hayley ^a   Saralahti, Anni ^a   Parikka, Mataleena ^a   Dramsi, Shaynoor ^c   Trieu Cuot, Patrick ^c   Poyart, Claire ^d,e   Rounioja, Samuli ^a,b   Rämet, Mika ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c CNRS   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Bacterial meningitis; Blood brain barrier; GBS; Group B Streptococcus; Streptococcus agalactiae; Zebrafish

Indexed keywords

EID: 84868158391     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dci.2012.07.007     Document Type: Article

References (55)

1. Allen J.P., Neely M.N. Trolling for the ideal model host: zebrafish take the bait. Future Microbiol. 2010, 5(4):563-569.
2. Baker C.J., Rench M.A., McInnes P. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine 2003, 21(24):3468-3472.
3. Banerjee A., Kim B.J., Carmona E.M., Cutting A.S., Gurney M.A., Carlos C., Feuer R., Prasadarao N.V., Doran K.S. Bacterial pili exploit integrin machinery to promote immune activation and efficient blood-brain barrier penetration. Nat. Commun. 2011, 2:462.
4. Barichello T., Lemos J.C., Generoso J.S., Cipriano A.L., Milioli G.L., Marcelino D.M., Vuolo F., Petronilho F., Dal-Pizzol F., Vilela M.C., Teixeira A.L. Oxidative stress, cytokine/chemokine and disruption of blood-brain barrier in neonate rats after meningitis by Streptococcus agalactiae. Neurochem. Res. 2011, 36(10):1922-1930.
5. Bottomley M.J., Serruto D., Sáfadi M.A., Klugman K.P. Future challenges in the elimination of bacterial meningitis. Vaccine 2012, 30:B78-B86.
6. Chaffin D.O., Mentele L.M., Rubens C.E. Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression. J. Bacteriol. 2005, 187(13):4615-4626.
7. Chang Y.C., Wang Z., Flax L.A., Xu D., Esko J.D., Nizet V., Baron M.J. Glycosaminoglycan binding facilitates entry of a bacterial pathogen into central nervous systems. PLoS Pathog. 2011, 7(6):e1002082.
8. Dahesh S., Hensler M.E., Van Sorge N.M., Gertz R.E., Schrag S., Nizet V., Beall B.W. Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics. Antimicrob. Agents Chemother. 2008, 52(8):2915-2918.
9. Doran K.S., Liu G.Y., Nizet V. Group B streptococcal beta-hemolysin/cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis. J. Clin. Invest. 2003, 112(5):736-744.
10. Doran K.S., Nizet V. Molecular pathogenesis of neonatal group B streptococcal infection: no longer in its infancy. Mol. Microbiol. 2004, 54(1):23-31.
11. Doran K.S., Engelson E.J., Khosravi A., Maisey H.C., Fedtke I., Equils O., Michelsen K.S., Arditi M., Peschel A., Niset V. Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J. Clin. Invest. 2005, 115(9):2499-2507.
12. Edmond K.M., Kortsalioudaki C., Scott S., Schrag S.J., Zaidi A.K., Cousens S., Heath P.T. Group B streptococcal disease in infants aged younger than 3months: systematic review and meta-analysis. Lancet 2012, 379(9815):547-556.
13. Ferrieri P., Burke B., Nelson J. Production of bacteremia and meningitis in infant rats with group B streptococcal serotypes. Infect. Immun. 1980, 27(3):1023-1032.
14. Forquin M.P., Tazi A., Rosa-Fraile M., Poyart C., Trieu-Cuot P., Dramsi S. The putative glycosyltransferase-encoding gene cylJ and the group B Streptococcus (GBS)-specific gene cylK modulate hemolysin production and virulence of GBS. Infect. Immun. 2007, 75(4):2063-2066.
15. Hanson B.R., Runft D.L., Streeter C., Kumar A., Carion T.W., Neely M.N. Functional analysis of the CpsA protein of Streptococcus agalactiae. J. Bacteriol. 2012, 194(7):1668-1678.
16. Hsieh J.C., Pan C.Y., Chen J.Y. Tilapia hepcidin (TH)2-3 as a transgene in transgenic fish enhances resistance to Vibrio vulnificus infection and causes variations in immune-related genes after infection by different bacterial species. Fish Shellfish Immunol. 2010, 29(3):430-439.
17. Ippolito D.L., James W.A., Tinnemore D., Huang R.R., Dehart M.J., Williams J., Wingerd M.A., Demons S.T. Group B Streptococcus serotype prevalence in reproductive-age women at a tertiary care military medical center relative to global serotype distribution. BMC Infect. Dis. 2010, 10:336.
18. Jault C., Pichon L., Chluba J. Toll-like receptor gene family and TIR-domain adapters in Danio rerio. Mol. Immunol. 2004, 40(11):759-771.
19. Jiang S.M., Cieslewicz M.J., Kasper D.L., Wessels M.R. Regulation of virulence by a two-component system in group B Streptococcus. J. Bacteriol. 2005, 187(3):1105-1113.
20. Johri A.K., Paoletti L.C., Glaser P., Dua M., Sharma P.K., Grandi G., Rappuoli R. Group B Streptococcus: global incidence and vaccine development. Nat. Rev. Microbiol. 2006, 4(12):932-942.
21. Kim K.S. Mechanisms of microbial traversal of the blood-brain barrier. Nat. Rev. Microbiol. 2008, 6(8):625-634.
22. Lamy M.C., Zouine M., Fert J., Vergassola M., Couve E., Pellegrini E., Glaser P., Kunst F., Msadek T., Trieu-Cuot P., Poyart C. CovS/CovR of group B streptococcus: a two-component global regulatory system involved in virulence. Mol. Microbiol. 2004, 54(5):1250-1268.
23. Larionov A., Krause A., Miller W. A standard curve based method for relative real-time PCR data processing. BMC Bioinformatics 2005, 21(6):62.
24. Leib S.L., Täuber M.G. Pathogenesis of bacterial meningitis. Infect. Dis. Clin. North Am. 1999, 13(3):527-548.
25. Lembo A., Gurney M.A., Burnside K., Banerjee A., de los Reyes M., Connelly J.E., Lin W.J., Jewell K.A., Vo A., Renken C.W., Doran K.S., Rajagopal L. Regulation of CovR expression in Group B streptococcus impacts blood-brain barrier penetration. Mol. Microbiol. 2010, 77(2):431-443.
26. Liu G.Y., Doran K.S., Lawrence T., Turkson N., Puliti M., Tissi L., Nizet V. Sword and shield: linked group B streptococcal beta-hemolysin/cytolysin and carotenoid pigment function to subvert host phagocyte defense. Proc. Natl. Acad. Sci. USA 2004, 101(40):14491-14496.
27. Maisey H.C., Doran K.S., Nizet V. Recent advances in understanding the molecular basis of group B Streptococcus virulence. Expert Rev. Mol. Med. 2008, 10:e27.
28. Meeker N.D., Trede N.S. Immunology and zebrafish: spawning new models of human disease. Dev. Comp. Immunol. 2008, 32(7):745-757.
29. Melin P. Neonatal group B streptococcal disease: from pathogenesis to preventive strategies. Clin. Microbiol. Infect. 2011, 17(9):1294-1303.
30. Miller J.D., Neely M.N. Zebrafish as a model host for streptococcal pathogenesis. Acta Trop 2004, 91(1):53-68.
31. Neely M.N., Pfeifer J.D., Caparon M. Streptococcus-zebrafish model of bacterial pathogenesis. Infect. Immun. 2002, 70(7):3904-3914.
32. Nizet V., Kim K.S., Stins M., Jonas M., Chi E.Y., Nguyen D., Rubens C.E. Invasion of brain microvascular endothelial cells by group B streptococci. Infect. Immun. 1997, 65(12):5074-5081.
33. Nizet V. Streptococcal β-hemolysins: genetics and role in disease pathogenesis. Trends Microbiol. 2002, 10(12):575-580.
34. Nusslein-Volhard C., Dahmn R. Zebrafish. A practical approach 2002, Oxford University Press, Oxford.
35. Pan C.Y., Peng K.C., Lin C.H., Chen J.Y. Transgenic expression of tilapia hepcidin 1-5 and shrimp chelonianin in zebrafish and their resistance to bacterial pathogens. Fish Shellfish Immunol. 2011, 31(2):275-285.
36. Peatman E., Liu Z. Evolution of CC chemokines in teleost fish: a case study in gene duplication and implications for immune diversity. Immunogenetics 2007, 59(8):613-623.
37. Phelan P.E., Pressley M.E., Witten P.E., Mellon M.T., Blake S., Kim C.H. Characterization of snakehead rhabdovirus infection in zebrafish (Danio rerio). J. Virol. 2005, 79(3):1842-1852.
38. Phelps, H.A., Runft, D.L., Neely, M.N. 2009. Adult zebrafish model of streptococcal infection. Curr. Protoc. Microbiol. 9, Unit-9D.1.
39. Poyart C., Pellegrini E., Gaillot O., Boumaila C., Baptista M., Trieu-Cuot P. Contribution of Mn-cofactored superoxide dismutase (SodA) to the virulence of Streptococcus agalactiae. Infect. Immun. 2001, 69(8):5098-5106.
40. Pressley M.E., Phelan P.E., Witten P.E., Mellon M.T., Kim C.H. Pathogenesis and inflammatory response to Edwardsiella tarda infection in the zebrafish. Dev. Comp. Immunol. 2005, 29(6):501-513.
41. Prouty M.G., Correa N.E., Barker L.P., Jagadeeswaran P., Klose K.E. Zebrafish-Mycobacterium marinum model for mycobacterial pathogenesis. FEMS Microbiol. Lett. 2003, 225(2):177-182.
42. Roca F.J., Mulero I., López-Muñoz A., Sepulcre M.P., Renshaw S.A., Meseguer J., Mulero V. Evolution of the inflammatory response in vertebrates: fish TNF-alpha is a powerful activator of endothelial cells but hardly activates phagocytes. J. Immunol. 2008, 181(7):5071-5081.
43. Rombout J.H., Abelli L., Picchietti S., Scapigliati G., Kiron V. Teleost intestinal immunology. Fish Shellfish Immunol. 2011, 31(5):616-626.
44. Rounioja S., Saralahti A., Rantala L., Parikka M., Henriques-Normark B., Silvennoinen O., Rämet M. Defense of zebrafish embryos against Streptococcus pneumoniae infection is dependent on the phagocytic activity of leukocytes. Dev. Comp. Immunol. 2012, 36(2):342-348.
45. Rubens C.E., Wessels M.R., Heggen L.M., Kasper D.L. Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc. Natl. Acad. Sci. USA 1987, 84(20):7208-7212.
46. Senn B.M., Visram Z., Meinke A.L., Neubauer C., Gelbmann D., Sinzinger J., Hanner M., Lundberg U., Boisvert H., Reinscheid D., von Gabain A., Nagy E. Monoclonal antibodies targeting different cell wall antigens of group B streptococcus mediate protection in both Fc-dependent and independent manner. Vaccine 2011, 29(24):4116-4124.
47. Skoff T.H., Farley M.M., Petit S., Craig A.S., Schaffner W., Gershman K., Harrison L.H., Lynfield R., Mohle-Boetani J., Zansky S., Albanese B.A., Stefonek K., Zell E.R., Jackson D., Thompson T., Schrag S.J. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin. Infect. Dis. 2009, 49(1):85-92.
48. Sullivan C., Kim C.H. Zebrafish as a model for infectious disease and human function. Fish Shellfish Immunol. 2008, 25(4):341-350.
49. Tazi A., Disson O., Bellais S., Bouaboud A., Dmytruk N., Dramsi S., Mistou M.Y., Khun H., Mechler C., Tardieux I., Trieu-Cuot P., Lecuit M., Poyart C. The surface protein HvgA mediates group B streptococcus hypervirulence and meningeal tropism in neonates. J. Exp. Med. 2010, 207(11):2313-2322.
50. Tazi A., Bellais S., Tardieux I., Dramsi S., Trieu-Cuot P., Poyart C. Group B Streptococcus surface proteins as major determinants for meningeal tropism. Curr. Opin. Microbiol. 2012, 15(1):44-49.
51. Tenenbaum T., Spellerberg B., Adam R., Vogel M., Kim K.S., Schroten H. Streptococcus agalactiae invasion of human brain microvascular endothelial cells is promoted by the laminin-binding protein Lmb. Microbes Infect. 2007, 9(6):714-720.
52. van der Sar A.M., Appelmelk B.J., Vandenbroucke-Grauls C.M., Bitter W. A star with stripes: zebrafish as an infection model. Trends Microbiol. 2004, 12(10):451-457.
53. Varela M., Dios S., Novoa B., Figueras A. Characterisation, expression and ontogeny of interleukin-6 and its receptors in zebrafish (Danio rerio). Dev. Comp. Immunol. 2012, 37(1):97-106.
54. Wu Z., Zhang W., Lu C. Comparative proteome analysis of secreted proteins of Streptococcus suis serotype 9 isolates from diseased and healthy pigs. Microb. Pathog. 2008, 45(3):159-166.
55. Yoder J.A., Nielsen M.E., Amemiya C.T., Litman G.W. Zebrafish as an immunological model system. Microbes Infect. 2002, 4(14):1469-1478.